Compare OPTT & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPTT | ZTEK |
|---|---|---|
| Founded | 1984 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Major Chemicals |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.0M | 89.3M |
| IPO Year | 2007 | N/A |
| Metric | OPTT | ZTEK |
|---|---|---|
| Price | $0.34 | $0.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 3.7M | 43.6K |
| Earning Date | 12-15-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,748,000.00 | $657,134.00 |
| Revenue This Year | $70.98 | N/A |
| Revenue Next Year | $106.21 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2225.73 |
| 52 Week Low | $0.30 | $0.62 |
| 52 Week High | $1.75 | $1.84 |
| Indicator | OPTT | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 39.77 | 44.84 |
| Support Level | $0.30 | $0.64 |
| Resistance Level | $0.38 | $0.75 |
| Average True Range (ATR) | 0.03 | 0.04 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 27.61 | 52.05 |
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.